Labcorp (LH) Investor Day 2026 summary

Strategic vision and market positioning

• Focus on leveraging scientific innovation, advanced technology, and global scale to drive growth and improve healthcare outcomes, with a strong emphasis on specialty testing in oncology, neurology, autoimmune, and women's health.

• Integrated diagnostics and biopharma laboratory services create a virtuous cycle of innovation, enabling seamless transition from drug development to real-world diagnostics and data insights.

• Positioned to capitalize on healthcare trends: aging population, personalized medicine, consumer engagement, and data-driven, tech-enabled care.

• Strategic partnerships, disciplined M&A, and investments in digital infrastructure support expansion and reinforce competitive advantages.

• Consumer-centric solutions and expanded access points aim to meet rising demand for personalized, convenient healthcare experiences.

Diagnostics and biopharma laboratory services highlights

• Diagnostics revenue projected to grow from $9.4B in 2023 to $11.5B in 2026, a 7% CAGR, driven by volume growth, specialty testing, and M&A.

• Specialty diagnostics (oncology, neurology, autoimmune, women's health) growing three times faster than the broader market, with $2B annual revenue and strong double-digit CAGRs.

• Over 90% of U.S. lives covered, 9,200+ patient access points, and 175M+ patient interactions annually.

• BLS revenue expected to grow from $2.8B in 2023 to $3.3B in 2026, a 6% CAGR, supported by strong R&D pipelines and increasing trial complexity.

• 85% of FDA drug and therapeutic approvals supported; global reach with 100+ countries served.

Technology and innovation

• Advanced technologies, including AI, robotics, and digital platforms, are central to enhancing operational efficiency, customer experience, and data-driven healthcare transformation.

• Proprietary data and AI platforms enable actionable insights, digital workflows, and next-generation enterprise capabilities.

• Over 100 new tests launched annually, with a focus on unmet needs in neurology, autoimmune, and women's health, supported by a comprehensive genetics portfolio and in-house genetic counselors.

• AI-powered tools like Labcorp Test Finder and MyLabcorp app streamline provider and patient experiences, improving satisfaction and operational efficiency.

• Digital pathology, automation, and data integration enhance clinical trial execution, accelerate drug development, and enable real-time insights for biopharma partners.